Biocytogen and SOTIO Biotech Partner on Colorectal Cancer ADC Candidate SOT109
China-based Biocytogen (HKG: 2315) has announced an option and licensing agreement with SOTIO Biotech, allowing...
SOTIO Biotech
Biocytogen Strikes Exclusive Deal with SOTIO Biotech for Next-Gen ADCs
Biocytogen (HKG: 2315), a leading biopharmaceutical company based in China, has announced a strategic research...